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ABSTRACT The genetics of a bird or flock has a
profound impact on its ability to resist disease, because
genetics define the maximum achievable performance
level. Careful attention should be paid to genetics as an
important component of a comprehensive disease
management program including high-level biosecurity,
sanitation, and appropriate vaccination programs. Some
specific genes (e.g., the MHC) are known to play a role
in disease resistance, but resistance is generally a
polygenic phenomenon. Future research directions will
expand knowledge of the impact of genetics on disease
resistance by identifying non-MHC genetic control of
resistance and by further elucidating mechanisms
regulating expression of genes related to immune
response.
(Key words: genetics, disease, Major Histocompatibility Complex, immunoglobulins, Salmonella enteritidis)
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INTRODUCTION
A basic tenet in all considerations of disease in
poultry is that the genetics of a bird or a flock defines
the maximum disease-resistance potential available. One
gene family, the MHC, has long been the subject of
intense investigation for its role in disease resistance.
Responses to a wide array of pathogens has been
demonstrated to be associated, in part, with the major
histocompatibility complex. Many other candidate genes
with a proven or potential role in disease resistance can
also be identified: cytokine genes, CD-encoding genes, T
cell receptor genes, Nramp1, growth hormone, and the
immunoglobulin genes. But resistance to most diseases
is likely controlled by polygenes. Both physiological
genetic and molecular genetic approaches can be used to
investigate polygenic control of immune response and
disease resistance. Divergent genetic selection for im-
munocompetence traits or disease resistance can
produce genetic lines to study for correlated changes in
their physiology and genetics. These divergent lines can
also be crossed to generate populations suitable for
mapping molecular markers for desirable performance.
Genetic selection, aided by molecular markers, can be
used to improve resistance to disease. But, ultimately, a
detailed understanding of the genetic basis of immune
response modulation will be needed to fully exploit the
discoveries of modern molecular genetics in improving
poultry health.
MAJOR HISTOCOMPATIBILITY COMPLEX
The best-characterized genetic control of disease
resistance and immune response in the chicken is that
associated with the MHC. The MHC genes have a
profound effect on the ability of animals to respond to
specific antigens. The MHC in the chicken was first
discovered as a blood group locus and is also termed the
B complex (Briles et al., 1950). Schierman and Nordskog
(1961) demonstrated that the B blood group locus in
chickens is linked to genes controlling histocompatibil-
ity. The MHC encodes for three classes of proteins
named B-F, B-L, and B-G (reviews, Lamont and Dietert,
1990; Lamont, 1993; Kaufman and Lamont, 1996). At the
molecular level, the chicken MHC has unique features
that will enhance its value as a marker for disease
resistance (Lamont, 1993, 1994; Kaufman and Lamont,
1996): the Class I and II genes overlap, therefore forming
extremely tight linkage; introns are relatively small (10%
of the size of most mammalian MHC); additional genes,
including ones with homology to mammalian genes
involved in lymphocyte activation and TAP2 (trans-
porter associated with antigen processing) have been
identified in the chicken MHC. Recently, a region
similar in sequence but genetically unlinked to the
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MHC, termed Rfp-Y has been mapped to the MHC-
bearing chromosome (Miller et al., 1994, 1996).
The chicken MHC antigens perform crucial functions
in the regulation of cellular communication in the
immune response. The cell surface antigens of the MHC
are unique to each genetically unique individual. This
allows immune reactions to occur against disease
organisms of an almost infinite spectrum, while simul-
taneously preserving the organism from self-destruction.
The control of the MHC over communication events
occurs at two levels: molecular interactions at the cell
surface and cellular cooperation in an immune response
(Dietert, 1987). The MHC cell surface glycoproteins
interact with both the antigen and with complementary
structures of other immune cells, generating an immune
response that is specific for the inducing antigen. For
different cell types of the immune system to communi-
cate effectively, they must share at least one MHC
haplotype, a phenomenon known as MHC restriction
(Vainio and Toivanen, 1987; Vainio et al., 1987).
The MHC restricts T cell cytotoxic reactions with
some virus-infected or transformed cells (Schat, 1994).
When cytotoxic T cells are combined with reticuloen-
dotheliosis virus (REV) infected cells, significant cytotox-
icity occurs only with syngeneic effector and target cell
combinations (MacCubbin and Schierman, 1986). A T
cell with antigen-restricted cytotoxic properties was
identified as the effector cell responsible for the MHC-
restricted cell-mediated cytotoxicity (Weinstock and
Schat, 1987). The MHC- and virus-restricted cytotoxic
cells may be an important immune surveillance mechan-
ism to stop proliferation of virally induced tumors
(Schierman and Collins, 1987).
Antibody production against a variety of antigens is
linked to the chicken MHC. Immune responses to
synthetic polypeptides such as (T, G)-A-L, GAT, and GT
are linked to the MHC in the chicken (Gunther et al.,
1974; Benedict et al., 1975; Pevzner et al., 1979). Antibody
titers to other soluble antigens (e.g., bovine serum
albumin) and to cellular antigens (e.g., Salmonella
pullorum bacterin, SRBC) are also associated with the
chicken MHC (Pevzner et al., 1975; Loudovaris et al.,
1990). Total serum IgG levels are associated with the B
complex (Rees and Nordskog, 1981; Pinard and van der
Zijpp, 1993).
In long-term selection experiments for antibody
response to SRBC conducted independently by Siegel
and colleagues and by van der Zijpp and colleagues,
correlated changes in MHC allelic frequencies were
detected (Dunnington et al., 1984; Pinard et al., 1993). The
MHC genotype explains part of the total variation in the
antibody levels, and the background genome also has a
substantial effect. In meat-type lines divergently selected
for early antibody response to Escherichia coli vaccina-
tion, differences occurred in frequency of MHC class IV
restriction fragment-length polymorphisms (RFLP)
bands (Uni et al., 1993). Recent studies with other probes
showed the Tap2 and B-F regions to be associated with
antibody production (Cahaner et al., 1997). In Leghorn
lines divergently selected for an index of im-
munocompetence traits, including antibodies, inflamma-
tory response, and reticuloendothelial activity, differ-
ences occurred in MHC genotype frequencies (Kean et
al., 1994a).
Genetic control of immunoresponsiveness can also be
investigated by measuring cell-mediated immunity. The
delayed wattle reaction (DWR) is commonly used as a
measure of cell-mediated immunity in the chicken
(Klesius et al., 1977). Both polyclonal inducers (e.g.,
phytohemagglutinin Taylor et al., 1987) and specific
inducers (e.g., Staphylococcus aureus, Cotter et al., 1987)
generate a cell-mediated immunity associated with the B
complex. Qureshi and colleagues (Qureshi et al., 1986,
1988) showed that chemotactic activity of chicken blood
mononuclear leukocytes, and activity and recruitment to
the peritoneal cavity of macrophages differed among the
15I5-B-congenic lines. Allograft and antibody responses
also varied by MHC in the same lines (Shen et al., 1984;
Bacon et al., 1987). Lines of chicken congenic for the
MHC were also used to demonstrate MHC associations
with CD4 and CD8 lymphocyte percentages and ratios
(Hala et al., 1991). The levels of total serum hemolytic
complement have been associated with the MHC in
chickens (Chanh et al., 1976) although specific compo-
nents were not found to segregate with the MHC (Koch,
1986).
Investigations of the fundamental biology of the
chicken MHC have been motivated by the association of
the chicken MHC with resistance to disease. Several
reviews (Bacon, 1987; Lamont, 1989, 1991, 1993; Gavora,
1990; Stevens, 1991) have surveyed this subject. The
best-characterized association of the MHC with disease
resistance is to Marek’s disease, a herpes virus-induced
lymphoma. This MHC influence has been mapped,
using recombinants, to the B-F|B-L region (Briles et al.,
1983; Hepkema et al., 1993). The MHC is associated with
traits of tumor incidence, mortality, and transient
paralysis induced by Marek’s disease virus. One specific
haplotype, B21, seems to convey Marek’s resistance to
many different genetic backgrounds. Variation in
response to Marek’s disease virus by sublines that are
identical at the B locus, however, illustrates the impor-
tance of non-MHC gene effects on Marek’s response
(Bacon, 1987). Genetic complementation with MHC
alleles of genes such as Ir-GAT or other genes affecting
antibody response may affect the susceptibility to
Marek’s disease (Steadham et al., 1987; Pinard et al.,
1993). The MHC also influences the response to other
virally induced diseases, including Rous sarcoma virus
tumors (Schierman et al., 1987; White et al., 1994), v-src
tumors (Taylor et al., 1992), and avian leukosis (Yoo and
Sheldon, 1992).
Resistance to diseases caused by nonviral pathogens
also has been associated with the MHC (Gavora, 1990).
These diseases include spontaneous autoimmune thyroi-
ditis (Rose, 1994), and coccidiosis (Lillehoj et al., 1989;
Caron et al., 1997). There is a relative paucity of
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information on the genetic control of bacterial disease in
chickens. Lamont et al. (1987a) demonstrated that genetic
control of resistance of a low dosage of Pasteurella
multocida was linked with genes of the chicken MHC
Class IV region. Cotter et al. (1992) reported MHC
linkage of resistance to Staphylococcus aureus.
Convincing evidence also exists for a genetic compo-
nent to resistance to Salmonella enteritidis in chickens.
Two groups have examined resistance to S. enteritidis in
several genetic lines and have found variation in 50%
lethal dose (LD 50) organ contamination, and bacterial
burden (Bumstead and Barrow, 1993; Guillot et al., 1995;
Protais et al., 1996). No evidence, however, was found
for MHC effect on Salmonella response. In a recent
report, several NRAMP1-linked markers were identified
to be associated with splenic bacterial burden 3 d after
intravenous inoculation of S. enteritidis (Girard-
Santosuosso et al., 1996). This generic association is an
excellent example of the application of comparative
genomics, in which a gene already defined in a
mammalian species is found to have similar structure
and function in the chicken (Hu et al., 1995, 1996).
The range and variety of diseases influenced by the
chicken MHC is, therefore, extensive. Additional factors,
such as non-MHC genetic background and vaccination,
have also been shown to interact with MHC genes in
influencing immune response and disease resistance
(Bacon and Witter, 1992; Dunnington et al., 1989, 1992).
An important observation that emerges from studies
on the MHC and disease, however, is that there is not a
single haplotype (perhaps with the exception of B21 and
Marek’s disease) that responds optimally in all genetic
backgrounds to all disease challenges. Given the many
different immune mechanisms involved in resistance to
disease and the many levels at which the MHC exerts
genetic control, this is not surprising. The repeated
associations with the MHC suggest that there are genes
for disease response within the MHC, but the lack of
consistent association with specific haplotypes suggests
that MHC-linked genes other than the classical MHC
class I and II genes may have a major influence.
Many diverse traits of economic importance such as
fertilization rate, embryonic mortality, hatchability,
juvenile and adult mortality, body weight, and egg
production are also influenced by MHC genotype
(Bacon, 1987; Dietert et al. 1991; Sander, 1993). In three
independent studies it was shown that long-term
selection for egg production traits and disease resistance
significantly altered MHC allelic frequencies (Simonsen
et al., 1982; Gavora et al., 1986; Lamont et al., 1987b).
Although different combinations of B haplotypes were
present in these selection studies, some general patterns
emerge. The B2 and B21 haplotypes may show overall
beneficial associations with economic traits in chickens.
Other studies have demonstrated MHC associations
with particular production traits, but not necessarily
consistency of specific MHC haplotypes or associated
traits (Dunnington et al., 1992; Kim et al., 1987, 1989;
Abplanalp et al., 1992; Sato et al., 1992).
The poultry breeding industry can currently apply
MHC information to selectively alter MHC allelic
frequencies for improvement of disease resistance and
vaccine response. Certain MHC alleles are associated
with Marek’s disease vaccination efficacy in commercial
genetic backgrounds (Bacon and Witter, 1994). Beneficial
MHC alleles can be increased in frequency or fixed
within a parent line. The extreme polymorphism of the
MHC (over 50 allelic forms) allows many options for
choice of specific MHC alleles in parent lines and allelic
combinations in commercial birds.
New applications of MHC manipulation to improve
avian health should incorporate new biotechnologies
(Lamont, 1994). Because antigen-binding specificity is
critical to effective poultry vaccine design, knowledge of
specific MHC types in the flock could allow specific
choices to optimize the vaccine-host MHC combination
or allow design of targeted recombinant vaccines (Schat,
1994; Bacon and Witter, 1994; Pharr et al., 1993; Witter
and Hunt, 1994). With the use of specific gene probes or
primers, DNA can be directly examined for allelic forms
of the MHC and MHC-linked genes and fine-mapping
of the specific loci contributing to disease resistance can
be conducted.
REGULATION OF GENES CONTROLLING
IMMUNE RESPONSE
Many studies of genetic control of disease resistance
focus on structural variation. For example, are different
alleles associated with differential response to pathogen
challenge? But it is becoming increasingly evident that
variation in structural genes and their encoded proteins
are only one source of variation in biological traits.
Variation in gene expression is another important source
of differences in performance. Factors controlling gene
expression must be understood in order to selectively
enhance expression (Lamont, 1994).
The regulation of expression of two genes of impor-
tance in disease resistance (MHC and immunoglobulin)
has been studied in the author’s lab. A 0.7 kb DNA
fragment from the 5¢ flanking region of a chicken MHC
class II B gene (the putative regulatory region) was
cloned into chloramphenicol acetyltransferase reporter
vectors and then transfected into a chicken macrophage
cell line. Positive orientation-dependent promoter ac-
tivity of the chicken DNA was detected in the reporter
construct containing an SV40 enhancer (Chen et al.,
1997). Deletion analysis revealed a short fragment in the
3¢ end that was crucial for the promoter function and
negative regulatory elements located further upstream.
Sequence analysis of the chicken MHC class II 5¢ region
suggests possible involvement of interferon, E 26
specific (ETS)-related proteins, and other factors as
candidates in regulating this promoter. An interferon-
rich chicken T cell line culture supernatant increased the
cell-surface expression of MHC class II antigens, as well
as class II promoter activity, in this macrophage cell line.
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TABLE 1. Correlations of Salmonella enteritidis burden in liver,




Liver 0.98* –0.13 0.00
Spleen 0.02 –0.17
Cecal content –0.87*
This functional characterization of a chicken MHC class
II B gene promoter will aid in understanding the
regulatory mechanisms that control the expression of
these genes of importance in immune function (Chen et
al., 1997).
Another category of regulatory elements are the Oct
transcription factors. The chicken immunoglobulin
lambda light chain promoter contains an octamer motif.
Two different lymphoid cell lines, DT40 (a B cell line)
and MSB1 (a T cell line), were used to test the activity of
the germline immunoglobulin promoter and the func-
tion of the octamer motif. The promoter was functional
only in B cells and then only in the presence of an SV40
enhancer. Mutation of the octamer motif eliminated the
transcriptional activity of the immunoglobulin promoter
(Heltemes et al., 1997). These results demonstrate that
the chicken immunoglobulin promoter functions simi-
larly to mammalian immunoglobulin promoters, in that
it plays a role in tissue specificity and requires both an
enhancer and an intact octamer motif for activity
(Heltemes et al., 1997). Full understanding of the
mechanisms that regulate genes of the immune system
pave the way toward targeted, specific gene expression
and perhaps bypassing tissue specificity in expression of
specific genes (e.g., MHC class II, immunoglobulins),
thereby opening new avenues to enhance disease
resistance.
SELECTION FOR ANTIBODY RESPONSE
In instances in which candidate gene information is
not readily available, the approach of selection for a trait
of immunocompetence can be employed to enhance
disease resistance. Antibody level is a popular choice,
because of the ease of repeated measurements and
generation of quantitative results. Also, antigens (such
as vaccines) can be used that have direct relevance to
specific diseases. Although the antibody-disease
resistance associations are widely accepted as a general
rule, the exact immune defense mechanism for most
specific diseases are poorly understood.
Many researchers have investigated the genetic
control of humoral immune response in egg-type
chickens. Siegel and Gross (1980) and Gross et al. (1980)
selected egg-type chickens for antibody production to
SRBC and tested the resistance of selected lines to
infectious diseases. The high-antibody production line
was more resistant to parasites and viruses, but not
bacteria, than the low antibody line. Subsequent studies
showed an interaction of antibody selection and MHC
with disease response (Martin et al., 1989). van der Zijpp
and coworkers (van der Zijpp and Leenstra, 1980; van
der Zijpp et al., 1982; van der Zijpp, 1983) also studied
humoral immune response of egg-type chickens to
SRBC, with emphasis on dose, genetic origin, interac-
tion, and correlation between primary and secondary
immune responses and between humoral and cell-
mediated responses. Studies with these lines have
elucidated a role for both antibody selection and MHC
type in influencing Marek’s disease response (Pinard et
al., 1993). Selection of egg-type chickens for antibody
response to Salmonella pullorum antigen (Pevzner et al.,
1981) was also successful. Selection for high and low
antibody response in meat-type birds, as well as for
early and late antibody production, has been success-
fully conducted (Pitcovski et al., 1987a,b; Leitner et al.,
1992; Yonash et al., 1996). Cell-mediated immunity of
chickens has also been examined and demonstrated to
be under the influence of genetic origin (van der Zijpp,
1983; Lamont and Smyth, 1984). Multitrait immune
response selection in egg-type chickens has also been
successful (Cheng and Lamont, 1988; Cheng et al., 1991;
Kean et al., 1994a,b). Thus, many studies have demon-
strated the feasibility of altering immunophysiology by
genetic selection.
For antibody selection to be effective in a program of
genetic selection for disease resistance, the variation in
antibody levels must be associated with variation in
response to disease. Fortunately, evidence is available
for association of antibody and resistance, including
examples of association of high antibody levels with
resistance to important bacterial pathogens such as E.
coli and Salmonella enteritidis. Lines selected for rapid,
early antibody response to E. coli were more resistant to
E. coli challenge (Leitner et al., 1990; Yonash et al., 1994).
Heritability (0.25 and 0.26 in two different broiler
breeder male lines) of antibody response to S. enteritidis
vaccine established the feasibility of identifying the
genetic basis of control of this response (Kaiser et al.,
1997, 1998). But because many components of the
immune response may be involved in resistance to any
specific disease, it was important to investigate the
relationship of S. enteritidis antibody and response to
live S. enteritidis challenge. To accomplish this goal, the
genetic relationship between S. enteritidis colonization
and S. enteritidis vaccine antibody response was deter-
mined in broiler breeder chicks. Half-sib groups of
chicks were either exposed to live S. enteritidis or
vaccinated against S. enteritidis. Serum antibodies at 3
wk (10 d postvaccination) were determined by ELISA
from the vaccinated chicks. The unvaccinated chicks
exposed to S. enteritidis were euthanatized at 3 or 6 wk,
and bacterial burden of selected sites was determined.
Sire means were calculated for all traits and used for
statistical analysis (Table 1). Antibody response to
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vaccination and number of S. enteritidis in cecal swab
cultures were significantly negatively correlated (–0.87).
Thus, the genetic potential for greater S. enteritidis
vaccine antibody response was associated with lesser S.
enteritidis cecal colonization in broiler breeder chicks
exposed to S. enteritidis. This information demonstrates
the feasibility of the goal of improving resistance to S.
enteritidis colonization by selecting for increased S.
enteritidis antibody response.
CONCLUSION
The inclusion of genetic selection for disease-resistant
genotypes can be a beneficial addition to a comprehen-
sive program of disease control. A total program
addresses all means of minimizing disease, including
eradication and sanitation, minimizing environmental
stressors, and employing good programs of biosecurity
and vaccination. Although perhaps expensive to imple-
ment, genetic resistance has many desirable features as
an approach to disease management. Identification of
genetic markers for disease resistance can obviate the
need for costly and hazardous disease-challenge testing.
True genetic potential can be identified, uncomplicated
by environmental effects in the assay system. Enhancing
immunocompetence can improve vaccine efficacy and
reduce need for antibiotic treatment, thereby reducing
residues. Desirable genotypes can be selected as early as
the day of hatch. The genetic improvements, although
perhaps small for each generation, are permanent and
cumulative.
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